Related Experiment Video
Updated: Jul 3, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Intracranial atherosclerosis]
Pablo Del Saz-Saucedo1, José Francisco Maestre-Moreno, Juan Francisco Arenillas-Lara
1Servicio de Neurología, Hospital Universitario Virgen de las Nieves, Granada, España. pablodelsaz@gmail.com
Insights
Intracranial atheromatosis, a leading cause of stroke, is increasingly diagnosed. This review covers its natural history and treatment options, highlighting the need for better therapies.
Area of Science:
- Neurology
- Vascular Neurology
- Cerebrovascular Disease
Context:
- Intracranial atheromatosis is a significant and increasingly recognized cause of stroke.
- Advances in non-invasive imaging have improved diagnosis and highlighted its prevalence.
- Previously underdiagnosed, it now demands greater clinical and research attention.
Purpose:
- To review the natural history of intracranial atheromatosis.
- To discuss current and potential therapeutic strategies for intracranial atheromatosis.
- To identify markers of poor outcome in patients with intracranial atheromatosis.
Summary:
- Intracranial atheromatosis, a major cause of stroke, is now frequently diagnosed due to advanced imaging.
- Research focuses on identifying prognostic markers and understanding mechanisms of cerebral ischemia.
- Current medical and endovascular treatments are limited, necessitating further therapeutic development.
Impact:
- Improved understanding of intracranial atheromatosis will aid clinical decision-making.
- This review provides a foundation for developing more effective treatments for stroke prevention and management.
- Highlights the need for enhanced therapeutic options for this prevalent cerebrovascular condition.
Abstract:
Until recently, intracranial atheromatosis was a probably underdiagnosed clinicopathological entity that was rarely studied in depth. In the last years the advance and expansion in the use of non-invasive diagnostic tools have led intracranial atheromatosis to the front page among the most prevalent causes of stroke worldwide. Important efforts have been accomplished with the aim of identifying markers of poor outcome, which, besides the underlying mechanisms of cerebral ischemia in these patients, are the most important factors on which clinical and therapeutic decisions should be based. To date, the therapeutic armamentarium is scarce and far from optimun, regarding medical and endovascular measures. In this review we address the most important aspects of the natural history and cure treatment of intracranial atheromatosis.
Related Concept Videos
Increased Intracranial Pressure ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Atherosclerosis I: Introduction
Transient Ischemic Attack l: Introduction